Radiosurgery is an Effective Treatment for Recurrent Esthesioneuroblastoma

A Multicenter Study

Jamie Van Gompel, Michael J. Link, Jason P. Sheehan, Zhiyuan Xu, David Mathieu, Hideyuki Kano, L. Dade Lunsford

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective Esthesioneuroblastoma (ENB) is a rare malignant neuroendocrine neoplasm that is prone to both local and metastatic recurrence. Local recurrence may often be treated with repeat resection. However, stereotactic radiosurgery (SRS) offers a noninvasive option. Design Prospective database review. Participants Gamma knife prospective databases were queried at all institutions within the North American Gamma Knife Consortium, 16 at the time of this report. All patients who had undergone SRS for ENB were included. Main Outcome Measure Response of recurrent ENB to SRS. Results A total of 31 locally recurrent tumors in 13 patients were treated with SRS. The median age was 49 years (range: 19-79 years). At a median follow-up of 36 months (range: 1-100 months), 13 (48%) treated tumors were smaller, 11 (41%) were stable, and 3 (11%) showed continued growth following SRS. Univariate analysis did not find any significant factor relating to failure of treatment. Notably, no treatment-related complications (0%) were observed in this cohort. Conclusion SRS appears to provide a safe and effective option for treatment of recurrent intracranial ENB. Overall, 89% of treated tumors were controlled in this multi-institutional study.

Original languageEnglish (US)
Pages (from-to)409-414
Number of pages6
JournalJournal of Neurological Surgery, Part B: Skull Base
Volume75
Issue number6
DOIs
StatePublished - Dec 1 2014

Fingerprint

Olfactory Esthesioneuroblastoma
Radiosurgery
Multicenter Studies
Neoplasms
Therapeutics
Databases
Recurrence
Treatment Failure
Outcome Assessment (Health Care)
Growth

Keywords

  • esthesioneuroblastoma
  • gamma knife
  • olfactory neuroblastoma
  • stereotactic radiosurgery

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Radiosurgery is an Effective Treatment for Recurrent Esthesioneuroblastoma : A Multicenter Study. / Van Gompel, Jamie; Link, Michael J.; Sheehan, Jason P.; Xu, Zhiyuan; Mathieu, David; Kano, Hideyuki; Lunsford, L. Dade.

In: Journal of Neurological Surgery, Part B: Skull Base, Vol. 75, No. 6, 01.12.2014, p. 409-414.

Research output: Contribution to journalArticle

Van Gompel, Jamie ; Link, Michael J. ; Sheehan, Jason P. ; Xu, Zhiyuan ; Mathieu, David ; Kano, Hideyuki ; Lunsford, L. Dade. / Radiosurgery is an Effective Treatment for Recurrent Esthesioneuroblastoma : A Multicenter Study. In: Journal of Neurological Surgery, Part B: Skull Base. 2014 ; Vol. 75, No. 6. pp. 409-414.
@article{234a26fa549b4dfd8d9bc1b0dee141f8,
title = "Radiosurgery is an Effective Treatment for Recurrent Esthesioneuroblastoma: A Multicenter Study",
abstract = "Objective Esthesioneuroblastoma (ENB) is a rare malignant neuroendocrine neoplasm that is prone to both local and metastatic recurrence. Local recurrence may often be treated with repeat resection. However, stereotactic radiosurgery (SRS) offers a noninvasive option. Design Prospective database review. Participants Gamma knife prospective databases were queried at all institutions within the North American Gamma Knife Consortium, 16 at the time of this report. All patients who had undergone SRS for ENB were included. Main Outcome Measure Response of recurrent ENB to SRS. Results A total of 31 locally recurrent tumors in 13 patients were treated with SRS. The median age was 49 years (range: 19-79 years). At a median follow-up of 36 months (range: 1-100 months), 13 (48{\%}) treated tumors were smaller, 11 (41{\%}) were stable, and 3 (11{\%}) showed continued growth following SRS. Univariate analysis did not find any significant factor relating to failure of treatment. Notably, no treatment-related complications (0{\%}) were observed in this cohort. Conclusion SRS appears to provide a safe and effective option for treatment of recurrent intracranial ENB. Overall, 89{\%} of treated tumors were controlled in this multi-institutional study.",
keywords = "esthesioneuroblastoma, gamma knife, olfactory neuroblastoma, stereotactic radiosurgery",
author = "{Van Gompel}, Jamie and Link, {Michael J.} and Sheehan, {Jason P.} and Zhiyuan Xu and David Mathieu and Hideyuki Kano and Lunsford, {L. Dade}",
year = "2014",
month = "12",
day = "1",
doi = "10.1055/s-0034-1378151",
language = "English (US)",
volume = "75",
pages = "409--414",
journal = "Journal of Neurological Surgery, Part B: Skull Base",
issn = "2193-6331",
publisher = "Thieme Medical Publishers",
number = "6",

}

TY - JOUR

T1 - Radiosurgery is an Effective Treatment for Recurrent Esthesioneuroblastoma

T2 - A Multicenter Study

AU - Van Gompel, Jamie

AU - Link, Michael J.

AU - Sheehan, Jason P.

AU - Xu, Zhiyuan

AU - Mathieu, David

AU - Kano, Hideyuki

AU - Lunsford, L. Dade

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Objective Esthesioneuroblastoma (ENB) is a rare malignant neuroendocrine neoplasm that is prone to both local and metastatic recurrence. Local recurrence may often be treated with repeat resection. However, stereotactic radiosurgery (SRS) offers a noninvasive option. Design Prospective database review. Participants Gamma knife prospective databases were queried at all institutions within the North American Gamma Knife Consortium, 16 at the time of this report. All patients who had undergone SRS for ENB were included. Main Outcome Measure Response of recurrent ENB to SRS. Results A total of 31 locally recurrent tumors in 13 patients were treated with SRS. The median age was 49 years (range: 19-79 years). At a median follow-up of 36 months (range: 1-100 months), 13 (48%) treated tumors were smaller, 11 (41%) were stable, and 3 (11%) showed continued growth following SRS. Univariate analysis did not find any significant factor relating to failure of treatment. Notably, no treatment-related complications (0%) were observed in this cohort. Conclusion SRS appears to provide a safe and effective option for treatment of recurrent intracranial ENB. Overall, 89% of treated tumors were controlled in this multi-institutional study.

AB - Objective Esthesioneuroblastoma (ENB) is a rare malignant neuroendocrine neoplasm that is prone to both local and metastatic recurrence. Local recurrence may often be treated with repeat resection. However, stereotactic radiosurgery (SRS) offers a noninvasive option. Design Prospective database review. Participants Gamma knife prospective databases were queried at all institutions within the North American Gamma Knife Consortium, 16 at the time of this report. All patients who had undergone SRS for ENB were included. Main Outcome Measure Response of recurrent ENB to SRS. Results A total of 31 locally recurrent tumors in 13 patients were treated with SRS. The median age was 49 years (range: 19-79 years). At a median follow-up of 36 months (range: 1-100 months), 13 (48%) treated tumors were smaller, 11 (41%) were stable, and 3 (11%) showed continued growth following SRS. Univariate analysis did not find any significant factor relating to failure of treatment. Notably, no treatment-related complications (0%) were observed in this cohort. Conclusion SRS appears to provide a safe and effective option for treatment of recurrent intracranial ENB. Overall, 89% of treated tumors were controlled in this multi-institutional study.

KW - esthesioneuroblastoma

KW - gamma knife

KW - olfactory neuroblastoma

KW - stereotactic radiosurgery

UR - http://www.scopus.com/inward/record.url?scp=84937432309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937432309&partnerID=8YFLogxK

U2 - 10.1055/s-0034-1378151

DO - 10.1055/s-0034-1378151

M3 - Article

VL - 75

SP - 409

EP - 414

JO - Journal of Neurological Surgery, Part B: Skull Base

JF - Journal of Neurological Surgery, Part B: Skull Base

SN - 2193-6331

IS - 6

ER -